Previous 10 | Next 10 |
Medulloblastoma is a rare type of brain tumor that is primarily found in children. It is estimated that about 350 cases of this illness are diagnosed annually. This cancer often resists treatment, which involves a combination of radiation, surgery and chemotherapy. This, combined with the diseas...
2023-11-20 17:42:09 ET More on CNS Pharmaceuticals Seeking Alpha’s Quant Rating on CNS Pharmaceuticals Financial information for CNS Pharmaceuticals For further details see: CNS Pharmaceuticals files to sell 3.76M shares of common stock for holders
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. The company today announced its confidence in sharing the results from an interim analysis on one of its lead ...
HOUSTON, TX / ACCESSWIRE / November 16, 2023 / Glioblastoma is a highly aggressive type of brain cancer with no cure, leading to a grim prognosis and average survival time of only 14 to 16 months . With no approved treatment for recurrent GBM anywhere in the world, it is considered one of the...
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting on its financial results for third quarter, the period ended Sept. 30, 2023; the company al...
- Enrollment numbers rise to 239 in ongoing potentially pivotal study of Berubicin for treatment of GBM; Expected full enrollment in December 2023 - Topline data from preplanned interim analysis from ongoing Berubicin potentially pivotal study expected in December 2023 - Raised $2.6 milli...
A team of researchers from Nottingham Trent University and the University of Sheffield is developing a first-of-its-kind finger-prick test to test for brain cancer. The research team says the simple test could make it easier to spot recurring brain tumors and even extend the lives of tens of tho...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
CNS Pharmaceuticals Inc. (CNSP) is expected to report for Q1 2024
Researchers from Stanford Medicine have found that lung cancer cells can spread to the brain and hide from the immune system by pretending to be “baby neurons.” After originating in the lungs, these cancer cells can metastasize into the brain and avoid detection by convincing neur...
News, Short Squeeze, Breakout and More Instantly...
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NYSE Market:
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 56.4% to $0.21 on volume of 112,154,340 shares Rivian Automotive Inc. (RIVN) rose 31.8% to $15.76 on volume of 70,797,368 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 48.3% to $...
New research carried out by scientists at the University of Birmingham and Newcastle University has determined that a new brain scan could decrease waiting times for diagnosis for children living with brain cancer. The most common form of brain cancer is medulloblastoma, which is further div...
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into securities purchase agreements with health-care focused institutional investors. The ag...